Apixaban is a new drug that acts by
Inhibiting TNF alpha
Inhibiting coagulation factor Xa
Inhibiting platelet aggregation
Activating plasminogen
Rivaroxaban and Apixaban are newer oral anticoagulants that act by inhibiting factor Xa. Newer oral anticoagulants that are currently being asked in the exams are: Direct thrombin inhibitor- Dabigatran Direct factor Xa inhibitors Apixaban Rivaroxaban Edoxaban Betrixaban
Hematology